Nautilus Biotechnology explores multiomics to mitigate space travel effects

Nautilus Biotechnology explores multiomics to mitigate space travel effects
Nautilus explores space biotech

Nautilus Biotechnology delves into the effects of space travel on the human body and seeks to mitigate these impacts through multiomics.

In a recent discussion, Parag Mallick from Nautilus Biotechnology sat down with Professor Afshin Beheshti from the University of Pittsburgh on the episode of #TranslatingProteomics to investigate this cutting-edge field. Multiomics refers to the integrative analysis of multiple 'omics' data, such as genomics, proteomics, and metabolomics, and it promises to enhance our understanding of the physiological changes experienced by astronauts during long-duration trips beyond Earth. This initiative aims to develop strategies to alleviate or manage these conditions effectively.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.